General Information of Drug Off-Target (DOT) (ID: OTQ8GP5L)

DOT Name Mucin-21 (MUC21)
Synonyms MUC-21; Epiglycanin
Gene Name MUC21
Related Disease
Carcinoma ( )
Depression ( )
Lung adenocarcinoma ( )
Major depressive disorder ( )
Myasthenia gravis ( )
Neoplasm ( )
Schizophrenia ( )
Squamous cell carcinoma ( )
Type-1 diabetes ( )
Epithelioid mesothelioma ( )
Idiopathic interstitial pneumonia ( )
Mesothelioma ( )
Systemic lupus erythematosus ( )
UniProt ID
MUC21_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF14654 ; PF05647
Sequence
MKMQKGNVLLMFGLLLHLEAATNSNETSTSANTGSSVISSGASTATNSGSSVTSSGVSTA
TISGSSVTSNGVSIVTNSEFHTTSSGISTATNSEFSTVSSGISIATNSESSTTSSGASTA
TNSESSTPSSGASTATNSDSSTTSSGASTATNSDSSTTSSEASTATNSESSTTSSGASTA
TNSESSTVSSRASTATNSESSTTSSGASTATNSESRTTSNGAGTATNSESSTTSSGASTA
TNSESSTPSSGAGTATNSESSTTSSGAGTATNSESSTVSSGISTVTNSESSTPSSGANTA
TNSESSTTSSGANTATNSDSSTTSSGASTATNSESSTTSSGASTATNSESSTTSSGASTA
TNSGSSTTSSGTSTATNSESSTVSSGASTATTSESSTTSSGASTATNSESSTVSSGASTA
TNSESSTTSSGANTATNSGSSVTSAGSGTAALTGMHTTSHSASTAVSEAKPGGSLVPWEI
FLITLVSVVAAVGLFAGLFFCVRNSLSLRNTFNTAVYHPHGLNHGLGPGPGGNHGAPHRP
RWSPNWFWRRPVSSIAMEMSGRNSGP
Tissue Specificity Expressed in lung, large intestine, thymus, and testis. Expressed in normal and malignant bronchial epithelial cells.
Reactome Pathway
Defective C1GALT1C1 causes TNPS (R-HSA-5083632 )
Defective GALNT12 causes CRCS1 (R-HSA-5083636 )
Dectin-2 family (R-HSA-5621480 )
O-linked glycosylation of mucins (R-HSA-913709 )
Termination of O-glycan biosynthesis (R-HSA-977068 )
Defective GALNT3 causes HFTC (R-HSA-5083625 )

Molecular Interaction Atlas (MIA) of This DOT

13 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Carcinoma DISH9F1N Strong Biomarker [1]
Depression DIS3XJ69 Strong Biomarker [2]
Lung adenocarcinoma DISD51WR Strong Altered Expression [3]
Major depressive disorder DIS4CL3X Strong Biomarker [2]
Myasthenia gravis DISELRCI Strong Genetic Variation [4]
Neoplasm DISZKGEW Strong Altered Expression [3]
Schizophrenia DISSRV2N Strong Biomarker [2]
Squamous cell carcinoma DISQVIFL Strong Biomarker [1]
Type-1 diabetes DIS7HLUB Strong Genetic Variation [5]
Epithelioid mesothelioma DIS17SNY Limited Altered Expression [6]
Idiopathic interstitial pneumonia DISH7LPY Limited Biomarker [7]
Mesothelioma DISKWK9M Limited Biomarker [6]
Systemic lupus erythematosus DISI1SZ7 Limited Genetic Variation [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Mucin-21 (MUC21). [9]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Fulvestrant DM0YZC6 Approved Fulvestrant increases the methylation of Mucin-21 (MUC21). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Mucin-21 (MUC21). [11]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Mucin-21 (MUC21). [10]
------------------------------------------------------------------------------------

References

1 Mucin 21 in esophageal squamous epithelia and carcinomas: analysis with glycoform-specific monoclonal antibodies.Glycobiology. 2012 Sep;22(9):1218-26. doi: 10.1093/glycob/cws082. Epub 2012 May 19.
2 Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.Mol Psychiatry. 2020 Jul;25(7):1420-1429. doi: 10.1038/s41380-018-0336-6. Epub 2019 Jan 9.
3 Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.PLoS One. 2019 Apr 11;14(4):e0215237. doi: 10.1371/journal.pone.0215237. eCollection 2019.
4 Risk for myasthenia gravis maps to a (151) ProAla change in TNIP1 and to human leukocyte antigen-B*08.Ann Neurol. 2012 Dec;72(6):927-35. doi: 10.1002/ana.23691. Epub 2012 Oct 10.
5 A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.Nature. 2007 Aug 2;448(7153):591-4. doi: 10.1038/nature06010. Epub 2007 Jul 15.
6 Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.Histopathology. 2019 Mar;74(4):545-554. doi: 10.1111/his.13775. Epub 2019 Jan 15.
7 Unique expression profiles of mucin proteins in interstitial pneumonia-associated lung adenocarcinomas.Histol Histopathol. 2019 Nov;34(11):1243-1254. doi: 10.14670/HH-18-114. Epub 2019 Apr 9.
8 GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.Genes Immun. 2014 Sep;15(6):347-54. doi: 10.1038/gene.2014.23. Epub 2014 May 29.
9 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
10 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.